WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$4.86
+3.40%Year over year
Reported trailing growth
- Revenue
- -30.4%
- EBITDA
- -52.4%
- EBIT
- -51.8%
- EPS
- -22.5%
- Free cash flow
- +6.9%
- Operating cash flow
- +7.3%
Forward estimates
Based on analyst estimates
- Revenue
- -69.1%
- EBITDA
- -39.1%
- EPS
- -28.5%
Three-year CAGR
- Revenue
- +127.1%
- EBITDA
- —
- EBIT
- -95.1%
- Net income
- —
- EPS
- -72.9%
- Free cash flow
- -23.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026